1. As a share of annual GDP, how much more does the United States spend on health care than the next highest spending country?
A. 15%
B. 25%
C. 35%
D. 45%
2. Which of the following is NOT a type of quality measure per the Donabedian model?
A. Structure
B. Process
C. Patient reported
D. Outcome
3. Which of the following organizations focuses on developing medication-related quality measures?
A. National Quality Forum
B. Pharmacy Quality Alliance
C. Pharmacy Quality Solutions
D. Medicare Payment Advisory Commission
4. In the context of quality measurement, attribution refers to the process of what?
A. Assigning patients to providers, pharmacies, and other entities for the purposes of identifying who is be responsible for the patient's care
B. Identifying the cause of a patient's illness
C. Assigning patients to health insurers who will manage their care
D. Assigning specific quality-related attributes to patients
5. Which of the following is FALSE regarding risk adjustment?
A. Risk adjustment creates a truer estimate of provider quality
B. Performance measures for performance-based pharmacy payment models are usually risk adjusted
C. Risk adjustment controls for patient-level factors that are outside of a provider's control
D. Individual measures can be risk adjusted
6. Which performance category for the Merit-based Incentive Payment System had a weight of 0% until 2019?
A. Quality
B. Promoting Interoperability
C. Improvement Activities
D. Cost
7. How can pharmacists add value to Medicare Shared Savings Program Accountable Care Organizations?
A. Improve quality
B. Decrease medical spending
C. Decrease prescription drug spending
D. Alternatives A and B are both correct
8. Which of the following is NOT a performance measure for the 2020 Medicare Star Ratings program?
A. Statin use in persons with diabetes
B. High risk medications in the elderly
C. Adherence to non-insulin diabetes medications
D. Comprehensive medication review completion rate
9. Primary challenges with pharmacy-level performance include all of the following EXCEPT
A. Cost of data collection
B. Quality measure selection
C. Low reliability
D. Lack of risk adjustment
10. All of the following are ways to improve pharmacy performance scores EXCEPT
A. Implementing specific services
B. Targeting outliers
C. Ignoring performance scores
D. Identifying a quality champion
Evaluation Questions
11. To what extent did the program meet objective #1?
A. Excellent
B. Very Good
C. Good
D. Fair
E. Poor
12. To what extent did the program meet objective #2?
A. Excellent
B. Very Good
C. Good
D. Fair
E. Poor
13. To what extent did the program meet objective #3?
A. Excellent
B. Very Good
C. Good
D. Fair
E. Poor
14. To what extent did the program meet objective #4?
A. Excellent
B. Very Good
C. Good
D. Fair
E. Poor
15. Rate the effectiveness of how well the program related to your educational needs:
A. Excellent
B. Very Good
C. Good
D. Fair
E. Poor
16. Rate how well the active learning strategies (questions, cases, discussions) were appropriate and effective learning tools:
A. Excellent
B. Very Good
C. Good
D. Fair
E. Poor
17. Rate the quality of the faculty:
A. Excellent
B. Very Good
C. Good
D. Fair
E. Poor
18. Rate the effectiveness and the overall usefulness of the material presented:
A. Excellent
B. Very Good
C. Good
D. Fair
E. Poor
19. Rate the appropriateness of the examination for this activity:
A. Excellent
B. Very Good
C. Good
D. Fair
E. Poor
20. Rate the effectiveness of how well the activity related to your practice needs:
A. Excellent
B. Very Good
C. Good
D. Fair
E. Poor
21. Rate the effectiveness of how well the activity will help you improve patient care:
A. Excellent
B. Very Good
C. Good
D. Fair
E. Poor
22. Will the information presented cause you to change your practice?
A. Yes
B. No
23. Are you committed to making these changes?
A. Yes
B. No
24. As a result of this activity, did you learn something new?
A. Yes
B. No
25. What is your practice setting or area of practice?
A. Community Pharmacy/Independent
B. Community Pharmacy/Chain
C. Hospital/Health Systems
D. Administrative/Pharmacy Director
E. Critical Care Pharmacy
F. Long-term Care
G. Managed Care/PBM
H. Oncology
I. Specialty Pharmacy
J. Industry/Manufacturing
26. How many years have you been in practice?
A. <5
B. 5 – 10
C. 11 – 20
D. >20